+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Synthetic Hormones Market - Global Forecast to 2030- Product Image
Synthetic Hormones Market - Global Forecast to 2030- Product Image
Sale

Synthetic Hormones Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533197
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Synthetic Hormones Market grew from USD 1.02 billion in 2024 to USD 1.17 billion in 2025. It is expected to continue growing at a CAGR of 14.52%, reaching USD 2.31 billion by 2030.

Over the past decade, the synthetic hormones market has experienced rapid evolution driven by advances in molecular engineering, shifting therapeutic demands, and tightening quality standards. Stakeholders-from manufacturers and researchers to healthcare providers and regulators-are collaborating to harness novel analogues and delivery platforms that enhance potency, reduce side effects, and improve patient adherence. Demand has surged across traditional hormone replacement therapies and emerging applications such as gender transition care, personalized thyroid management, and long-acting contraceptives. Environmental considerations and sustainability initiatives have gained prominence, prompting investment in greener synthesis methods and circular supply chain models aligned with broader healthcare ESG objectives. At the same time, digital health platforms and data-driven dosing algorithms are enabling more precise regimens, strengthening clinical outcomes and unlocking new patient segments. Regulatory frameworks continue to adapt, balancing expedited approvals for breakthrough therapies with rigorous safety and efficacy standards. This introductory overview sets the stage for an in-depth analysis of transformative shifts, tariff impacts, segmentation insights, regional dynamics, corporate strategies, and actionable recommendations designed to inform leaders and guide strategic decision-making in a dynamic global environment.

Transformative Shifts Reshaping the Synthetic Hormones Landscape

Synthetic hormones are at the nexus of several transformative forces reshaping the pharmaceutical landscape. Breakthroughs in peptide synthesis and bioidentical analogues are broadening the therapeutic window for both established and novel hormone treatments. Biomanufacturing innovations-such as continuous processing and flow chemistry-are reducing production costs and enhancing batch-to-batch consistency. Meanwhile, precision medicine is unlocking tailored therapies that account for individual metabolic profiles and genetic polymorphisms, elevating patient outcomes in menopause management, transgender health, and endocrine disorders. Beyond scientific advances, strategic partnerships between biotech start-ups and major pharmaceutical players are accelerating pipeline development and facilitating market entry. Digital therapeutics and remote monitoring tools are also gaining traction, enabling real-time hormone level tracking and dose optimization. Finally, sustainability initiatives are leading to the adoption of greener solvents and waste minimization strategies, reflecting a shift toward environmentally conscious production. Together, these developments are forging a competitive landscape where agility, innovation, and regulatory foresight determine market leadership.

Cumulative Impact of United States Tariffs on Synthetic Hormones in 2025

The introduction of new United States tariffs in 2025 has created both challenges and strategic opportunities across the synthetic hormones supply chain. Increased duties on key intermediates and finished formulations have elevated raw material costs, prompting manufacturers to reassess sourcing strategies and renegotiate supplier agreements. In response, several firms are diversifying their procurement footprints, establishing secondary supply routes in tariff-exempt regions, and pursuing backward integration to mitigate margin erosion. Meanwhile, pricing pressures are driving optimization of logistics networks, with some players consolidating warehousing operations and leveraging free trade zones to streamline cross-border movements. On the regulatory front, stakeholders anticipate accelerated review of localized production sites to offset import costs, potentially reshaping global manufacturing footprints. Despite these headwinds, tariff-induced innovation has spurred process intensification and automation investments, enabling leaner operations and faster time-to-market. As the full ramifications unfold, companies that swiftly adapt supply chain architectures and maintain transparent stakeholder communications will be best positioned to sustain profitability and competitiveness.

Key Segmentation Insights: Hormone Types, Applications, End-Users, Formulations, Sales Channels

When analyzing by hormone type, Androgens evaluated through methyltestosterone and testosterone formulations continue to dominate male health protocols, while Estrogen subdivided into estradiol, estriol, and estrone derivatives supports a broad spectrum of women’s health and menopause therapies. Progestin categories such as levonorgestrel, medroxyprogesterone, and norethindrone drive contraceptive innovation, and Thyroid Hormones including levothyroxine, liothyronine, and emerging desiccated thyroid extracts capture growing attention for personalized endocrine care. On the application front, contraception options span potential long-acting reversible implants, injectables, and oral pills, while gender transition protocols focus on body contouring, hormone replacement therapy, and voice modification enhancements. Menopause management solutions target hot flashes, mood swings, and night sweats, and transgender health services differentiate between feminizing and masculinizing hormone regimens tailored to individual goals. End-user channels vary from endocrinology and family planning clinics to in-patient and outpatient hospital departments, as well as academic research institutions, clinical trial environments, and both traditional and online pharmacies. Formulation types encompass injectable formats like pre-filled syringes and vials, oral pills and tablets for convenience, topical creams, gels, and patches for sustained release, alongside future developments such as biodegradable implants and nanoparticle carriers. Sales strategies pivot on direct engagement with clinics and hospitals, distributor partnerships with specialty pharmacies and third-party networks, digital storefronts hosted on drugstore websites and e-pharmacies, and nascent mobile health applications and telemedicine platforms seeking to expand reach and patient access.

Key Regional Insights: Americas, EMEA, and Asia-Pacific Dynamics

The Americas remain a cornerstone region, driven by robust R&D investments in the United States and growing demand across Canada and Latin America. Market participants in North America benefit from well-established reimbursement frameworks and a strong focus on personalized care, while pharmaceutical hubs in Brazil and Mexico are emerging as competitive manufacturing centers. In Europe, competitive dynamics are influenced by harmonized regulatory standards within the EU and innovation clusters in Germany, Switzerland, and Scandinavia. The Middle East and Africa segment, though smaller, is marked by rapid infrastructure development and public health initiatives targeting endocrine disorders, creating nascent growth pockets. In the Asia-Pacific region, vaccine-style rollouts of digital health platforms and telemedicine services are expanding access to hormone therapies in China, India, Japan, and Australia. Local manufacturing capabilities in China and India are scaling up to meet both domestic and export demand, offering cost advantages but also prompting scrutiny of quality assurance measures. Southeast Asian nations are advancing generic substitution policies and reimbursement models, further democratizing patient access. Across all regions, strategic alliances and localized innovation hubs are essential to navigate diverse regulatory landscapes and capture tailored market opportunities.

Key Company Insights Driving Innovation and Market Expansion

American Regent, Inc. by Daiichi Sankyo Group Company has intensified its focus on injection-based hormone therapies and niche endocrine indications, leveraging global R&D resources to optimize biologics manufacturing. BIOTE MEDICAL, LLC. emphasizes peptide analogues with improved safety profiles, while CSBio pioneers advanced formulation technologies, including nanoparticle delivery systems for sustained-release hormone administration. Endo Pharmaceuticals Inc. remains a leader in branded hormone replacements and injectables, strategically expanding its portfolio through targeted acquisitions and co-development partnerships. Ferring International Center S.A. builds on its expertise in reproductive health and urology, integrating precision dosing algorithms within its hormone replacement regimens. Lyndra Therapeutics champions user-friendly, weekly oral delivery platforms that aim to disrupt traditional daily dosing paradigms. Pfizer Inc. continues to leverage its global footprint and regulatory experience to accelerate approvals for next-generation hormone analogues, pairing clinical trial data with real-world evidence to drive market uptake. Slayback Pharma LLC stands out for its collaborative ecosystem model, partnering with academic institutions to advance novel hormone pathways and expand therapeutic indications. Collectively, these organizations are shaping competitive benchmarks through differentiated pipelines, strategic alliances, and manufacturing excellence.

Actionable Recommendations for Synthetic Hormone Industry Leaders

To maintain competitive advantage and sustain growth, industry leaders should:
  1. Invest in flexible manufacturing platforms incorporating continuous processing and single-use technologies to scale rapidly in response to tariff-induced supply shifts.
  2. Expand strategic collaborations with biotech innovators and academic centers to accelerate the commercialization of next-generation hormone analogues and delivery systems.
  3. Integrate digital health solutions-remote monitoring tools, adherence apps, and data analytics-to deliver personalized dosing regimens and strengthen patient engagement.
  4. Diversify global supply chains by establishing regional hubs in tariff-advantaged zones, renegotiating supplier agreements, and pursuing backward integration for key intermediates.
  5. Embed sustainability KPIs across R&D and manufacturing processes, focusing on greener solvents, waste minimization, and circular supply models to meet emerging ESG requirements and investor expectations.

Conclusion: Navigating the Future of Synthetic Hormones

The synthetic hormones arena is characterized by rapid technological progress, evolving regulatory environments, and differentiated regional dynamics. Market players who excel at integrating scientific innovation with agile supply chain strategies will capture the highest value opportunities. Embracing digital health and precision medicine platforms provides a strategic edge by enhancing patient outcomes and fostering brand loyalty. At the same time, proactive engagement with emerging sustainability standards and tariff mitigation tactics will secure operational resilience. Companies that forge robust partnerships-whether through co-development, licensing, or acquisitions-will accelerate time-to-market for breakthrough therapies. Lastly, a thorough understanding of regional reimbursement landscapes and end-user preferences will be critical in tailoring product launches and commercial models. By synthesizing these insights into cohesive corporate strategies, stakeholders can navigate complexity, seize emerging niches, and drive long-term growth in an increasingly competitive global market.

Market Segmentation & Coverage

This research report categorizes the Synthetic Hormones Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Androgens
    • Methyltestosterone
    • Testosterone
  • Estrogen
    • Estradiol
    • Estriol
    • Estrone
  • Progestin
    • Levonorgestrel
    • Medroxyprogesterone
    • Norethindrone
  • Thyroid Hormones
    • Levothyroxine
    • Liothyronine
    • Potential Future: Desiccated Thyroid Extracts
  • Contraception
    • Future: Long-Acting Reversible Contraceptives
    • Injectables
    • Oral Pills
  • Gender Transition
    • Body Contouring
    • Hormone Replacement Therapy
    • Voice Modification
  • Menopause Management
    • Hot Flashes
    • Mood Swings
    • Night Sweats
  • Transgender Health
    • Feminizing Hormones
    • Masculinizing Hormones
  • Clinics
    • Endocrinology Clinics
    • Family Planning Clinics
  • Hospitals
    • In-Patient Care
    • Out-Patient Care
  • Research Institutions
    • Academic Research
    • Clinical Trials
  • Retail Pharmacies
    • Online Pharmacies
    • Traditional Pharmacies
  • Future Developments
    • Biodegradable Implants
    • Nanoparticles
  • Injectable
    • Pre-Filled Syringes
    • Vials
  • Oral
    • Pills
    • Tablets
  • Topical
    • Creams
    • Gels
    • Patches
  • Direct Sales
    • To Clinics
    • To Hospitals
  • Distributor Channel
    • Specialty Pharmacies
    • Third-Party Distributors
  • Online Sales
    • Drugstore Websites
    • E-Pharmacies
  • Potential Future Channels
    • Mobile Health Apps
    • Telemedicine Platforms

This research report categorizes the Synthetic Hormones Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Synthetic Hormones Market to delves into recent significant developments and analyze trends in each of the following companies:

  • American Regent, Inc. by Daiichi Sankyo Group Company
  • BIOTE MEDICAL, LLC.
  • CSBio
  • Endo Pharmaceuticals Inc.
  • Ferring International Center S.A.
  • Lyndra Therapeutics
  • Pfizer Inc.
  • Slayback Pharma LLC

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Synthetic Hormones Market, by Hormone Type
8.1. Introduction
8.2. Androgens
8.2.1. Methyltestosterone
8.2.2. Testosterone
8.3. Estrogen
8.3.1. Estradiol
8.3.2. Estriol
8.3.3. Estrone
8.4. Progestin
8.4.1. Levonorgestrel
8.4.2. Medroxyprogesterone
8.4.3. Norethindrone
8.5. Thyroid Hormones
8.5.1. Levothyroxine
8.5.2. Liothyronine
8.5.3. Potential Future: Desiccated Thyroid Extracts
9. Synthetic Hormones Market, by Application Area
9.1. Introduction
9.2. Contraception
9.2.1. Future: Long-Acting Reversible Contraceptives
9.2.2. Injectables
9.2.3. Oral Pills
9.3. Gender Transition
9.3.1. Body Contouring
9.3.2. Hormone Replacement Therapy
9.3.3. Voice Modification
9.4. Menopause Management
9.4.1. Hot Flashes
9.4.2. Mood Swings
9.4.3. Night Sweats
9.5. Transgender Health
9.5.1. Feminizing Hormones
9.5.2. Masculinizing Hormones
10. Synthetic Hormones Market, by End-User
10.1. Introduction
10.2. Clinics
10.2.1. Endocrinology Clinics
10.2.2. Family Planning Clinics
10.3. Hospitals
10.3.1. In-Patient Care
10.3.2. Out-Patient Care
10.4. Research Institutions
10.4.1. Academic Research
10.4.2. Clinical Trials
10.5. Retail Pharmacies
10.5.1. Online Pharmacies
10.5.2. Traditional Pharmacies
11. Synthetic Hormones Market, by Formulation Type
11.1. Introduction
11.2. Future Developments
11.2.1. Biodegradable Implants
11.2.2. Nanoparticles
11.3. Injectable
11.3.1. Pre-Filled Syringes
11.3.2. Vials
11.4. Oral
11.4.1. Pills
11.4.2. Tablets
11.5. Topical
11.5.1. Creams
11.5.2. Gels
11.5.3. Patches
12. Synthetic Hormones Market, by Sales Channel
12.1. Introduction
12.2. Direct Sales
12.2.1. To Clinics
12.2.2. To Hospitals
12.3. Distributor Channel
12.3.1. Specialty Pharmacies
12.3.2. Third-Party Distributors
12.4. Online Sales
12.4.1. Drugstore Websites
12.4.2. E-Pharmacies
12.5. Potential Future Channels
12.5.1. Mobile Health Apps
12.5.2. Telemedicine Platforms
13. Americas Synthetic Hormones Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Synthetic Hormones Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Synthetic Hormones Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. American Regent, Inc. by Daiichi Sankyo Group Company
16.3.2. BIOTE MEDICAL, LLC.
16.3.3. CSBio
16.3.4. Endo Pharmaceuticals Inc.
16.3.5. Ferring International Center S.A.
16.3.6. Lyndra Therapeutics
16.3.7. Pfizer Inc.
16.3.8. Slayback Pharma LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SYNTHETIC HORMONES MARKET MULTI-CURRENCY
FIGURE 2. SYNTHETIC HORMONES MARKET MULTI-LANGUAGE
FIGURE 3. SYNTHETIC HORMONES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SYNTHETIC HORMONES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SYNTHETIC HORMONES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SYNTHETIC HORMONES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY METHYLTESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TESTOSTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ESTRADIOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ESTRIOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ESTRONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY LEVONORGESTREL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MEDROXYPROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY NORETHINDRONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY LEVOTHYROXINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY LIOTHYRONINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE: DESICCATED THYROID EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY FUTURE: LONG-ACTING REVERSIBLE CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ORAL PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY BODY CONTOURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY VOICE MODIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOT FLASHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MOOD SWINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY NIGHT SWEATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY FEMINIZING HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MASCULINIZING HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ENDOCRINOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY FAMILY PLANNING CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY IN-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OUT-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TRADITIONAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY BIODEGRADABLE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TO CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TO HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY DRUGSTORE WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY E-PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MOBILE HEALTH APPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TELEMEDICINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, 2018-2030 (USD MILLION)
TABLE 174. CANADA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 175. CANADA SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 176. CANADA SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 177. CANADA SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 178. CANADA SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 179. CANADA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 180. CANADA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 181. CANADA SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 182. CANADA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 183. CANADA SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 184. CANADA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. CANADA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 186. CANADA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. CANADA SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 188. CANADA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 189. CANADA SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 190. CANADA SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 191. CANADA SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 192. CANADA SYNTHETIC HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 193. CANADA SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 194. CANADA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. CANADA SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 196. CANADA SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. CANADA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 198. CANADA SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, 2018-2030 (USD MILLION)
TABLE 199. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 200. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 201. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 202. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 203. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 204. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 205. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 206. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 207. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 208. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 209. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 211. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 212. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 213. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 214. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 215. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 216. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 217. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 218. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 219. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 221. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 223. MEXICO SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 242. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 243. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, 2018-2030 (USD MILLION)
TABLE 249. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 290. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, 2018-2030 (USD MILLION)
TABLE 301. CHINA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 302. CHINA SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 303. CHINA SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 304. CHINA SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 305. CHINA SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 306. CHINA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 307. CHINA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 308. CHINA SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 309. CHINA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 310. CHINA SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 311. CHINA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 312. CHINA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 313. CHINA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 314. CHINA SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 315. CHINA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 316. CHINA SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 317. CHINA SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 318. CHINA SYNTHETIC HORMONES MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 319. CHINA SYNTHETIC HORMONES MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 320. CHINA SYNTHETIC HORMONES MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 321. CHINA SYNTHETIC HORMONES MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. CHINA SYNTHETIC HORMONES MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 323. CHINA SYNTHETIC HORMONES MARKET SIZE, BY DISTRIBUTOR CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. CHINA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 325. CHINA SYNTHETIC HORMONES MARKET SIZE, BY POTENTIAL FUTURE CHANNELS, 2018-2030 (USD MILLION)
TABLE 326. INDIA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE TYPE, 2018-2030 (USD MILLION)
TABLE 327. INDIA SYNTHETIC HORMONES MARKET SIZE, BY ANDROGENS, 2018-2030 (USD MILLION)
TABLE 328. INDIA SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, 2018-2030 (USD MILLION)
TABLE 329. INDIA SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN, 2018-2030 (USD MILLION)
TABLE 330. INDIA SYNTHETIC HORMONES MARKET SIZE, BY THYROID HORMONES, 2018-2030 (USD MILLION)
TABLE 331. INDIA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 332. INDIA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 333. INDIA SYNTHETIC HORMONES MARKET SIZE, BY GENDER TRANSITION, 2018-2030 (USD MILLION)
TABLE 334. INDIA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 335. INDIA SYNTHETIC HORMONES MARKET SIZE, BY TRANSGENDER HEALTH, 2018-2030 (USD MILLION)
TABLE 336. INDIA SYNTHETIC HORMONES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 337. INDIA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 338. INDIA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 339. INDIA SYNTHETIC HORMONES MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 340. INDIA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 341. INDIA SYNTHETIC HORMONES MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 342. INDIA SYNTHETIC HORMONES MARKET SIZE, BY FUTURE DEVELOPMENTS, 2018-2030 (USD MILLION)
TABLE 343. INDIA

Companies Mentioned

  • American Regent, Inc. by Daiichi Sankyo Group Company
  • BIOTE MEDICAL, LLC.
  • CSBio
  • Endo Pharmaceuticals Inc.
  • Ferring International Center S.A.
  • Lyndra Therapeutics
  • Pfizer Inc.
  • Slayback Pharma LLC

Methodology

Loading
LOADING...

Related Topics

Related Reports

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Bioidentical Hormones Market - Global Forecast to 2030 - Product Image

Bioidentical Hormones Market - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Synthetic Hormones Market Report 2025 - Product Image

Synthetic Hormones Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Human Growth Hormone Market by Route of Administration, Type, Distribution, Application - Global Forecast 2025-2030 - Product Image

Human Growth Hormone Market by Route of Administration, Type, Distribution, Application - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Hormone Therapy Market Report 2025 - Product Image

Hormone Therapy Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Synthetic Hormone Market

The Synthetic Hormone market is a subset of the Endocrine and Metabolic Disorders Drugs market. Synthetic Hormones are drugs that are designed to mimic the effects of naturally occurring hormones in the body. These drugs are used to treat a variety of endocrine and metabolic disorders, such as diabetes, thyroid disorders, and growth hormone deficiencies. Synthetic Hormones are also used to treat menopausal symptoms, such as hot flashes and night sweats. Synthetic Hormones are typically administered orally, through injections, or through topical creams. The market for Synthetic Hormones is expected to grow in the coming years due to the increasing prevalence of endocrine and metabolic disorders, as well as the aging population. Some companies in the Synthetic Hormone market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.